Phagos develops personalised bacteriophage solutions as a sustainable alternative to antibiotics
Phagos has raised $29.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Phagos's investors include Bpifrance, Entrepreneurs First, Hoxton Ventures, Acurio Ventures, Capagro.
Phagos is headquartered in Paris, France.
Phagos develops personalised bacteriophage solutions as a sustainable alternative to antibiotics
Phagos is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phagos — Funding & Investors." VCBacked, October 8, 2025, https://www.vcbacked.co/company/phagos. Accessed July 19, 2026.
VCBacked. (2025). Phagos — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/phagos
{{cite web |title=Phagos — Funding & Investors |url=https://www.vcbacked.co/company/phagos |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated